As the first step in the decommissioning of the site has been converted to read-only mode.

Here are some tips for How to share your SAS knowledge with your professional network.

Gerhard Svolba

From sasCommunity
Jump to: navigation, search

GerhardSvolba1.jpg DQFA Draft Cover01.jpg DPFA Vortrag Kopenhagen 2012.JPG DPFA Cover1.JPG

Personal Profile

  • Lives and works in Vienna, Austria
  • Married, 3 children
  • PhD in Statistics, Master in Business Informatics, Master in Statistics
  • Sailor, family father, outdoor-fan
  • Blogging under Gerhard's Blog
  • Email contact.

Author at SAS Press

Analytic Expert and Senior Solution Architect at SAS Austria

  • Product Manager for SAS Analytic Products: SAS Enterprise Miner, SAS Forecast Studio, SAS/STAT, SAS/ETS, SAS/HPF, SAS/QC, SAS/OR
  • Design and implementation of business intelligence projects with focus on analytics
    • Analytical CRM Projects at large Austrian Telecommuncations, Banking and Insurance Companies
      • Customer Retention and Churn Prediction for residential and business customers
      • Customer Survival Analysis - Prediction of the expected remaining "lifetime" of residential customers
      • Behaviour Segmentation of Business Customers
      • Segmenation based on product usage and call behaviour of residential customers in order to define target groups for marketing campaigns
      • Next best offer analyses in order to prioritze the next most appropriate marketing action per customer
      • Customer Lifetime Value and Customer Profitability Analysis
    • Design and Implementation of the analytical part of a Basel II compliant credit scoring projects, including the approval by the Austrian financial authorities, at a mid-size Austrian bank
    • Analytical method to analyse the influence of various factors on the sales numbers in the retail business
    • Design and Implementation of a „Sales Forecasting und Planning“ project at a worldwide operating Austrian manufacturing company
      • Analytical models to forecast sales numbers of products with a long history
      • New product forecasting: Design of similarity models to predict sales numbers for new products or products with short history
  • Programme Coordinator for the SAS Austria User Group "SAS Club", see also Austria -- SAS Club
  • Business Intelligence Architect and SAS Programmer. Find my samples under Gerhard's Samples

Other professional engagements

Contributions at and

Other functions

Former assistent professor at the Department for Medical Statistics, University of Vienna

  • Statistical Quality Control in Clinical Trials
    • Controlled Clinical Trials; Volume (issue): 20 (6) 1999 ; 519-530, Gerhard Svolba, Peter Bauer: Statistical Quality Control in Clinical Trials
    • PhD-Thesis: WUV-Verlag, Wien 1999, Band 60, ISBN: 3-85114-489-9, Statistical Quality Control in Clinical Trials
  • GCP-compliant data handling in clinical trials
    • 1995 – 2004: Creation of a data management and analysis system based on international standards (GCP) for the largest Austrian dermatology trial; management of this trial as clincial data manager
  • Statistical Consulting
    • Journal of Cataract & Refractive Surgery 04/98 Andreas Kruger, MD, Jörg Schauersberger, MD, Oliver Findl, MD, Vanessa Petternel, Gerhard ** Svolba, MSc, Michael Amon, MD, Postoperative Inflammation after Clear Coronel Incision and Sclerocorneal Incision
    • Transfusion 1999;39(11-12):1235-8 B. Ulm, G. Svolba, M.R. Ulm, G. Bernaschek, S. Panzer Male fetuses are particlarly affected by maternal Rhesus-D alloimmunization
    • Ophtahalmologica E. Risk, B. Mühlbauer, I. Ruhswurm, K. Krepler, A. Derbolay, G. Svolba, A. Rieger, A. Wedrich Evaluation of CMV Retinitits Management - Outcome of four years CMV Therapy
    • Obstetrics & Gynecology B. Ulm, L. Kirchner, G. Svolba, J. Deutinger, G. Bernaschek, S. Panzer Adjuvant Fetal High Dose Immunoglobulin Administration in Prenatal Anemia Due to Rhesus Alloimmunization
    • Thromb Haemost 2000;83:661-665 Watzke HH , Forberg E , Svolba G , Jimenez-Boj E , Krinninger B A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation
    • European Urology Vol. 36, No. 3, 1999 Georg Schatzl, Stephan Madersbacher, Johann Hofbauer, Armin Pycha, Werner J. Reiter, Gerhard Svolba, Michael Marberger The Impact of Urinary Extravasation after Radical Retropubic Prostatectomy on Urinary Incontinence and Anastomotic Strictures
    • J Cataract Refract Surg 25: 1116-1120 Schauersberger J, Kruger A, Abela C, Müllner-Eidenböck A, Petternel V, Svolba G & Amon M Course of postoperative inflammation after implantation of 4 types of foldable intraocular lenses
    • The Royal College of Ophthalmologists of London - Vol. 14 Part 1 Jorg Schauersberger, Andreas Kruger, Andrea Mullner-Eidenbock, Vanessa Petternel, Claudette Abela, Gerhard Svolba, Michael Amon Long-term disorders of the blood-aqueous barrier after small-incision cataract surgery
    • Wien Klin Wochenschr 111: 1019-1026. Ch. Druml, G. Svolba, E. A. Singer, F. O. Bonkovsky and P. Bauer Twenty years of the ethics committee at the medical faculty of the university of Vienna
    • Eur Urol 1999;36:187-190 (DOI:10.1159/000067995) Schatzl, G. ; Madersbacher, S. ; Hofbauer, J. ; Pycha, A. ; Reiter, W.J. ; Svolba, G. ; Marberger, M. The Impact of Urinary Extravasation after Radical Retropubic Prostatectomy on Urinary Incontinence and Anastomotic Strictures
    • Ophthalmologica 1998;212:239-243 (DOI:10.1159/000027300) Ries, E. ; Mühlbauer, B. ; Ruhswurm, I. ; Krepler, K. ; Derbolav, A. ; Svolba, G. ; Rieger, A. ; Wedrich, A. Evaluation of Cytomegalovirus Retinitis Management
    • Journal of Clinical Oncology Dec 1, 2005; 23 (34) Erika Richtig, H. Peter Soyer, Martin Posch, Ulrike Mossbacher, Peter Bauer, Ligia Teban, Gerhard Svolba, Ingrid H. Wolf, Peter Fritsch, Bernhard Zelger, Beatrix Volc-Platzer, Walter Gebhart, Paul Mischer, Andreas Steiner, Wolf Pachinger, Helmut Hintner, Friedrich Gschnait, Klemens Rappersberger, Peter Pilarski, and Hubert Pehamberger Prospective, Randomized, Multicenter, Double-Blind Placebo-Controlled Trial Comparing Adjuvant Interferon Alfa and Isotretinoin With Interferon Alfa Alone in Stage IIA and IIB Melanoma